Generic Name: cyclosporine
Brand Name: Ikervis
Manufacturer: Santen Canada Incorporated
Therapeutic Area: keratitis, severe
Indications: keratitis, severe
Submission Type: Initial
Project Status: Withdrawn
Biosimilar: No
Fee Schedule: Schedule A
Key Milestones2 | |
|---|---|
| Call for patient input posted | April 17, 2017 |
| Patient group input closed | June 06, 2017 |
| Clarification: - Patient input submission received | |
| Patient input summary sent for review to patient input groups | June 26, 2017 |
| Patient group comments on input summary closed | July 04, 2017 |
| Clarification: - Patient input summary feedback received | |
| Submission received | May 15, 2017 |
| Submission accepted for review | May 30, 2017 |
| Review initiated | May 31, 2017 |
| Clarification: - Voluntarily withdrawn by the manufacturer on 2017-July-11 | |